Ludger Ltd, Abingdon, UK
Ludger Ltd is a bioscience company specialising in technology for the measurement and control of biopharmaceutical glycosylation. Our technology is used in the quality control of FDA- and EMEA-approved biopharmaceuticals worldwide, and can be used to support IND submissions. Clients include leading pharmaceutical and biotechnology companies throughout the world.
Ludger manufactures a comprehensive range of kits and reagents for ICH-compliant glycoprofiling of biopharmaceuticals throughout the drug development cycle. Products include kits for glycan release, labelling and purification, labelled glycans, HPLC/UHPLC columns, endo and exo-glycosidases and glycoprotein standards. We can design and execute appropriate glycoprofiling programmes for your therapeutic and transfer optimised glycoprofiling methods to your laboratories.
Our analytical services for glycan characterization include: sialic acid profiling (to compare levels of NeuAc vs NeuGc), quantitative monosaccharide analysis, Level 1 and Level 2 profiling of N- and O-glycans by a range of orthogonal HPLC and MS methods and detailed exoglycosidase sequencing.
For more information please visit our website, http://www.ludger.com